Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT06038383 |
Other study ID # |
5.802.024 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
August 1, 2023 |
Est. completion date |
December 2024 |
Study information
Verified date |
September 2023 |
Source |
University of Sao Paulo |
Contact |
Jacqueline C Macedo-Dias, Masters |
Phone |
+5515991929494 |
Email |
jacqueline.macedo[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Patients with chronic kidney diseases, especially those requiring hemodialysis, are
characterized by an increased risk of numerous morbidities. This is a condition that
significantly impacts the patient's quality of life, leads to dependence, and involves
high-cost treatment. The physical condition of chronic kidney disease patients falls well
below the recommendations set by the World Health Organization, indicating effective
difficulties in the approaches used for implementing physical activity programs. New
approaches must be considered. Physical activity through virtual reality can foster greater
social integration of patients with physical exercise during hemodialysis, enabling improved
quality of life and decreased frailty levels for these individuals due to its playful and
motivational nature.
Objective: To assess changes in heart rate variability modulation and the quality of life of
chronic kidney disease patients undergoing virtual reality-based exercise during hemodialysis
sessions.
Methods: A longitudinal, controlled, randomized crossover clinical trial. The chronic kidney
disease groups will be divided into two groups, Group A (GA) and Group B (GB). Group GA will
engage in 10 interventions, with each intervention involving the completion of 3 sessions of
a Virtual Reality (VR) game lasting 5 minutes each, totaling 15 minutes of exercise. Group GB
will participate in 10 interventions, with each intervention comprising 15 minutes of
physical exercise on a cycle ergometer, referred to here as conventional exercise.
After the initial 10 interventions, the groups will switch exercises; that is, GA will cease
VR interventions and begin another 10 interventions with conventional exercise, while GB will
stop conventional exercise interventions and start another 10 interventions with VR.
The Kidney Disease Quality of Life Short Form questionnaire, Beck's Anxiety and Depression
Inventory, and the International Physical Activity Questionnaire will also be administered to
all groups.
Description:
The objective of this Longitudinal CrossOver Clinical Trial is to compare changes in heart
rate variability modulation in chronic renal patients undergoing conventional physical
exercise and in a virtual environment during hemodialysis sessions.
The main questions it aims to answer are:
What are the differences in changes in heart rate variability modulation between chronic
renal patients who undergo conventional physical exercise before and during hemodialysis
sessions, and those who engage in virtual environment exercises?
How does the virtual environment influence changes in heart rate variability modulation
compared to conventional physical exercise in chronic renal patients before and during
hemodialysis sessions?
What is the relative effectiveness of conventional physical exercise compared to virtual
environment exercise in improving heart rate variability modulation in chronic renal patients
before and during hemodialysis sessions?
Group A will participate in 10 interventions, each intervention consisting of playing 3
rounds of a Virtual Reality game lasting 5 minutes, totaling 15 minutes of exercise. Group B
will participate in 10 interventions, each intervention consisting of 15 minutes of physical
exercise on a cycle ergometer, referred to here as conventional exercise.
After the initial 10 interventions,there will be a 1-week washout period and the groups will
switch exercises. Heart rate and respiratory rate, oxygen saturation, systemic blood
pressure, laboratory tests, as well as the Kidney Disease Quality of Life Short Form
questionnaire, the Beck Anxiety and Depression Inventory, and the International Physical
Activity Questionnaire will be assessed in all groups.